ImmunoBiology is a biotechnology company that is focused on developing products that could have applications in the treatment of a range of infectious diseases such as meningitis, tuberculosis, influenza and hepatitis C. The company’s technology is based on a the discovery that a group of proteins known as “heat shock proteins” has a pivotal role in controlling the normal immune response to infections. Scancell’s ImmunoBody technology has been licensed for use in non-cancer treatments.
Immunobiology Ltd
Vaccine developer
Company information
Company:
Private
Fund:
Growth Capital VCT
Sector:
Biotech
Status:
Current
You might also be interested in...
Integrated technologies and services business enabling the delivery of genomic medicine